Skip to main content
Signal8
Launch Terminal

DEXCOM INC (DXCM)

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

DexCom, Inc. logo

DexCom, Inc.

NASDAQ:DXCMHealthcare
+2.95%$82.29
AH$82.29+0.00%vs close
Mkt Cap$30.69B
Float375.93M
O/S372.95M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
DexCom, Inc. logoNASDAQ:DXCM$82.29+2.95%
Phase Distribution
35 lead-sponsored trials·4 active·24 completed
Phase 11
Phase 41
Not applicable33
(135 more as collaborator)
Status Overview
Not yet recruiting1
Active, not recruiting4
Completed24
Unknown6

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 4
    Active, not recruiting

    Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia

    Real-Time Continuous Glucose Monitoring

    Type 2 Diabetes on Insulin

    Enrollment
    200
    Start
    Nov 2025
    Primary Completion
    Nov 2026est.
    Completion
    Dec 2026est.
    NCT07603284
  • Phase 1
    Active, not recruiting

    Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor

    Basal insulin

    Type 2 Diabetes

    Enrollment
    45
    Start
    Apr 2023
    Primary Completion
    Jan 2026
    Completion
    Jan 2027est.
    NCT07681375
  • Observational
    Completed

    Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System

    -

    Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

    Enrollment
    53
    Start
    May 2008
    Primary Completion
    Jun 2008
    Completion
    Jul 2008
    NCT00722241
  • Observational
    Completed

    Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting

    IVBG

    Diabetes, Hyperglycemia

    Enrollment
    50
    Start
    Jun 2009
    Primary Completion
    Jul 2009
    Completion
    Aug 2009
    NCT00925080
  • Observational
    Completed

    Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)

    Continuous Glucose Monitoring

    Type 1 Diabetes Mellitus

    Enrollment
    14
    Start
    Jul 2008
    Primary Completion
    Aug 2008
    Completion
    Feb 2009
    NCT00939289
  • Observational
    Completed

    Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy

    CGM

    Type 1 Diabetes Mellitus

    Enrollment
    120
    Start
    Apr 2009
    Primary Completion
    -
    Completion
    -
    NCT01104142
  • Not applicable
    Completed

    Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System

    DexCom™ G4 Continuous Glucose Monitoring System

    Diabetes Mellitus

    Enrollment
    60
    Start
    Feb 2010
    Primary Completion
    Apr 2010
    Completion
    Apr 2010
    NCT01111370
  • Observational
    Completed

    Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus

    -

    Diabetes Mellitus

    Enrollment
    64
    Start
    Aug 2010
    Primary Completion
    Oct 2010
    Completion
    Nov 2010
    NCT01185496
  • Not applicable
    Completed

    Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

    Continuous Glucose Monitoring of glucose levels (Dexcom)

    Diabetes

    Enrollment
    72
    Start
    Dec 2011
    Primary Completion
    Feb 2012
    Completion
    Feb 2012
    NCT01514292
  • Observational
    Completed

    Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

    -

    Diabetes

    Enrollment
    21
    Start
    Nov 2011
    Primary Completion
    Dec 2011
    Completion
    Dec 2011
    NCT01514305
  • Observational
    Completed

    Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus

    Dexcom G4 CGM System

    Diabetes Mellitus

    Enrollment
    13
    Start
    May 2012
    Primary Completion
    Jan 2013
    Completion
    Jun 2013
    NCT01627184
  • Observational
    Completed

    Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System

    -

    Diabetes Mellitus

    Enrollment
    60
    Start
    May 2012
    Primary Completion
    Dec 2012
    Completion
    Dec 2012
    NCT01627210
  • Observational
    Completed

    Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus

    -

    Pediatric Subjects With Diabetes Mellitus

    Enrollment
    176
    Start
    Jul 2012
    Primary Completion
    Dec 2012
    Completion
    -
    NCT01667185
  • Not applicable
    Completed

    Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm

    Continuous Glucose Monitoring

    Diabetes Mellitus

    Enrollment
    51
    Start
    Dec 2013
    Primary Completion
    Mar 2014
    Completion
    Mar 2014
    NCT02087995
  • Not applicable
    Completed

    Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes

    Continuous Glucose Monitor

    Diabetes Mellitus

    Enrollment
    316
    Start
    Sep 2014
    Primary Completion
    Nov 2016
    Completion
    Nov 2016
    NCT02282397
  • Observational
    Completed

    Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics

    -

    Diabetes Mellitus

    Enrollment
    30
    Start
    Sep 2012
    Primary Completion
    Oct 2012
    Completion
    Oct 2012
    NCT02363907
  • Observational
    Completed

    G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

    -

    Diabetes Mellitus

    Enrollment
    97
    Start
    Jan 2016
    Primary Completion
    Apr 2016
    Completion
    Apr 2016
    NCT02696252
  • Not applicable
    Completed

    Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System

    CGM

    Diabetes Mellitus

    Enrollment
    304
    Start
    May 2016
    Primary Completion
    Jul 2017
    Completion
    Sep 2017
    NCT02880267
  • Not applicable
    Completed

    Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

    Acetaminophen Challenge (G6 CGM)

    Diabetes Mellitus

    Enrollment
    70
    Start
    Feb 2017
    Primary Completion
    Mar 2017
    Completion
    Mar 2017
    NCT03087877
  • Observational
    Unknown status

    Continuous Monitoring and Control of Hypoglycemia

    Continuous Glucose Monitoring (CGM)

    Diabetes

    Enrollment
    1,388
    Start
    Oct 2017
    Primary Completion
    Dec 2023est.
    Completion
    Dec 2023est.
    NCT03340831
  • Not applicable
    Completed

    Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

    Dexcom G6 CGM System, Blood glucose meter

    Diabetes Mellitus, Type 2

    Enrollment
    176
    Start
    Jul 2018
    Primary Completion
    Jan 2021
    Completion
    Jan 2021
    NCT03566693
  • Not applicable
    Completed

    Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)

    CGM, SMBG

    Diabetes Mellitus, Type 2

    Enrollment
    72
    Start
    Sep 2018
    Primary Completion
    May 2020
    Completion
    Nov 2020
    NCT03620357
  • Observational
    Unknown status

    Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

    Dexcom CGM System

    Diabetes

    Enrollment
    60
    Start
    May 2019est.
    Primary Completion
    May 2019est.
    Completion
    May 2019est.
    NCT03935191
  • Observational
    Unknown status

    Prediabetes and Type 2 Diabetes Data Collection Study

    G6

    Diabetes Mellitus, Type 2, Pre-diabetes

    Enrollment
    306
    Start
    Jul 2020
    Primary Completion
    Feb 2022est.
    Completion
    Feb 2022est.
    NCT04503239
  • Observational
    Completed

    Glucose Risk Assessment in Employer Populations

    Dexcom G6 Continuous Glucose Monitor (CGM) System

    Diabetes, Pre-diabetes +1

    Enrollment
    207
    Start
    Apr 2019
    Primary Completion
    Jul 2019
    Completion
    Aug 2021
    NCT04529824

1-25 of 35

Search ClinicalTrials.gov for “Dexcom”